Ecuador vs Libya: Enforcing contracts: Court structure and proceedings (0-5)
Enforcing contracts: Court structure and proceedings (0-5) over time
- Ecuador
- Libya
How they compare
Ecuador currently reports 2 DB17-20 methodology against 2 DB17-20 methodology in Libya, a difference of 0 DB17-20 methodology.
The two have swapped places 1 time across 5 shared years of data; in 2015 it was Ecuador ahead.
Ecuador ranks 157th and Libya ranks 157th of 188 countries.
Ecuador has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher enforcing contracts: court structure and proceedings (0-5), Ecuador or Libya?
- Ecuador, at 2 DB17-20 methodology against 2 DB17-20 methodology in Libya as of 2019.
- What is the difference in enforcing contracts: court structure and proceedings (0-5) between Ecuador and Libya?
- 0 DB17-20 methodology, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Libya?
- 5 years are reported by both, from 2015 to 2019.
- How do Ecuador and Libya rank globally for enforcing contracts: court structure and proceedings (0-5)?
- Ecuador ranks 157th and Libya ranks 157th of 188 countries.
- Where does this data come from?
- The World Bank, published as Enforcing contracts: Court structure and proceedings (0-5) (DB17-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The court structure and proceedings evaluates five aspects of the court system: (i) whether a specialized commercial court, division or section is available; (ii) whether a small claims court and/or simplified procedure for small claims is available; (iii) whether pretrial attachment of defendant's movable assets is available; (iv) whether new cases are assigned randomly and through an automated system to judges; and (v) whether a woman’s testimony in court carries the same evidentiary weight as that of a man's. The index is computed based on the methodology in the DB17-20 studies.